Compare Stocks

Star Diamond Corporation engages in the exploration, development, and production of diamonds in Canada. The company's principal mineral properties include the Star Kimberlite property and the Orion South Kimberlite property located in Fort à la Corne area of Saskatchewan, Canada. It also holds a 50% interest in the Buffalo Hills project located in north central Alberta, Canada. The company was formerly known as Shore Gold Inc. and changed its name to Star Diamond Corporation in February 2018. The company was incorporated in 1985 and is headquartered in Saskatoon, Canada.

LeadFX Inc., a mining company, focuses on the development of lead-silver projects. Its principal asset is the Paroo Station mine, a restart-ready lead carbonate mine, located in Western Australia. The company was formerly known as Ivernia Inc. and changed its name to LeadFX Inc. in October 2015. The company is headquartered in Burswood, Australia. LeadFX Inc. is a subsidiary of Sentient Group of Global Resource Funds.

Margaux Resources Ltd., a polymetallic exploration company, engages in the acquisition, exploration, and development of mineral properties in the Kootenay Arc in Southeastern British Columbia in Canada. The company primarily explores for zinc, gold, and tungsten deposits. It holds an option agreement to acquire a 100% interest in the Jackpot/Oxide, Ore Hill, Aspenex, Bayonne, Sheep Creek, Canex, and Old Timer properties located in Salmo, British Columbia. The company was formerly known as Carmen Energy Inc. and changed its name to Margaux Resources Ltd. in July 2013. Margaux Resources Ltd. was incorporated in 2009 and is based in Calgary, Canada.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.